Lumexa Imaging Holdings, Inc.
LMRIUnited States
6 filed reports · 131 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
6 reports · Dec 2025 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 14 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 4 | 14 | Dec 2025 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 2 | 541 | Mar 2026 to Jun 2026 |
Financial data
131 concepts · 555 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial125 concepts · 459 facts · Dec 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents6 · Mar 2025 to Jun 2026
- Stockholders equity (US GAAP)6 · Mar 2025 to Jun 2026
- Common stock par or stated value per share5 · Dec 2025 to Jun 2026
- Accounts payable and other accrued liabilities current4 · Dec 2025 to Jun 2026
- Accounts payable current4 · Dec 2025 to Jun 2026
- Accounts receivable pledging arrangement4 · Dec 2025 to Jun 2026
- Accrued insurance current4 · Dec 2025 to Jun 2026
- Accrued professional fees current4 · Dec 2025 to Jun 2026
- Additional paid in capital common stock4 · Dec 2025 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value4 · Mar 2025 to Jun 2026
- Allocated share based compensation expense4 · Mar 2025 to Jun 2026
- Amortization of cloud computing implementation costs4 · Mar 2025 to Jun 2026
- Amortization of financing costs4 · Mar 2025 to Jun 2026
- Assets4 · Dec 2025 to Jun 2026
- Assets current4 · Dec 2025 to Jun 2026
- Capital expenditures incurred but not yet paid4 · Mar 2025 to Jun 2026
- Capitalized cloud computing implementation costs4 · Mar 2025 to Jun 2026
- Capitalized computer software amortization14 · Mar 2025 to Jun 2026
- Capital lease obligations incurred4 · Mar 2025 to Jun 2026
- Cash and cash equivalents at carrying value4 · Dec 2025 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect4 · Mar 2025 to Jun 2026
- Common stock shares authorized4 · Dec 2025 to Jun 2026
- Common stock shares issued4 · Dec 2025 to Jun 2026
- Common stock shares outstanding4 · Dec 2025 to Jun 2026
Segment3 concepts · 58 facts · Mar 2025 to Jun 2026
- Revenue34 · Mar 2025 to Jun 2026
- Operating Segments12 · Mar 2025 to Jun 2026
- Segment reporting other item amount12 · Mar 2025 to Jun 2026
Product1 concepts · 24 facts · Mar 2025 to Jun 2026
- Revenue24 · Mar 2025 to Jun 2026
Guidance2 concepts · 14 facts · Mar 2026 to Aug 2026
- Revenue Guidance8 · Mar 2026 to Aug 2026
- EPS (Diluted) Guidance6 · Mar 2026 to Aug 2026
Segments
82 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments3 members · 58 facts
- Outpatient20 · Mar 2025 to Jun 2026
- Professional20 · Mar 2025 to Jun 2026
- Intersegments Eliminations18 · Mar 2025 to Jun 2026
Product or service5 members · 24 facts
- Health Care Patient Service8 · Mar 2025 to Jun 2026
- Investment Advisory Management And Administrative Service4 · Mar 2025 to Jun 2026
- Management Fee And Other Revenue4 · Mar 2025 to Jun 2026
- Management Fee And Other Revenue Related Party4 · Mar 2025 to Jun 2026
- Patient Service Revenue Related Party4 · Mar 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 12, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.